Navigated to Lung Cancer Considered

Lung Cancer Considered

IASLC
Next episode tomorrow.
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda
317 episodes  •  0 archived  •  
Virtual Tumor Board: Resectable EGFR NSCLC
July 1
July 1
39 mins
FDA Approval: Taletrectinib and ROS1 NSCLC
June 24
June 24
29 mins
IASLC - ASCO 2025 Highlights
June 6
June 6
55 mins
FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC
May 27
May 27
33 mins
LCC in Korean: Lung Cancer Updates & Future Directions
May 23
May 23
33 mins
Global Advances and Persistent Disparities in Lung Cancer Treatment
May 20
May 20
47 mins
Dr. Bryant Lin Teaching My Cancer
May 6
May 6
41 mins
AACR 2025 Highlights
May 2
May 2
52 mins
What You Should Know About RET-Positive NSCLC: Live from TexasLung25
April 29
April 29
30 mins
Excuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25
April 22
April 22
40 mins